7Baggers

We provide you with 20 years of free, institutional-grade data for TMDX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of TMDX. Explore the full financial landscape of TMDX stock.

Reported DateCIKTickerType
2025-07-301756262TMDX10-QUrl
2025-05-081756262TMDX10-QUrl
2025-02-271756262TMDX10-KUrl
2024-10-291756262TMDX10-QUrl
2024-08-011756262TMDX10-QUrl
2024-05-021756262TMDX10-QUrl
2024-02-271756262TMDX10-KUrl
2023-11-081756262TMDX10-QUrl
2023-08-041756262TMDX10-QUrl
2023-05-041756262TMDX10-QUrl
2023-02-271756262TMDX10-KUrl
2022-11-041756262TMDX10-QUrl
2022-08-031756262TMDX10-QUrl
2022-05-051756262TMDX10-QUrl
2022-03-011756262TMDX10-KUrl
2021-11-091756262TMDX10-QUrl
2021-08-061756262TMDX10-QUrl
2021-05-071756262TMDX10-QUrl
2021-03-111756262TMDX10-KUrl
2020-11-061756262TMDX10-QUrl
2020-08-071756262TMDX10-QUrl
2020-05-061756262TMDX10-QUrl
2020-03-171756262TMDX10-KUrl
2019-11-081756262TMDX10-QUrl
2019-08-081756262TMDX10-QUrl
2019-06-121756262TMDX10-QUrl
2019-04-051756262TMDXS-1Url

TransMedics Group, Inc
(NASDAQ:TMDX) 

TMDX stock logo

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring...

Founded: 1998
Full Time Employees: 109
CEO: Waleed H. Hassanein  
Sector: Healthcare
Industry: Medical Devices

Share this website to your friends
The information provided in this report about TMDX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.